http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
정현식,이상헌,유화승,김경석,Jung, Hyun-sik,Lee, Sang-hun,Yoo, Hwa-seung,Kim, Kyung-suk 대한한방내과학회 2016 大韓韓方內科學會誌 Vol.37 No.3
Objective: The purpose of this study was to present the clinical practice guideline of Korean medicine for malignant lymphoma.Background: Malignant lymphoma is the tenth most common cancer in Korea. The two main types of lymphoma are Hodgkin’s disease and non-Hodgkin’s lymphoma. Non-Hodgkin’s lymphomas are more common, comprising nearly 95 percent of all lymphomas. In China, the traditional Chinese medicine clinical guidelines for malignant lymphoma were published in 2014. Therefore, there is growing need for a clinical practice guideline in Korea, which has not thus far existed. This clinical practice guideline was created by reviewing the Chinese clinical practice guideline and Korean clinical reports. This study will be helpful in understanding malignant lymphoma and in understanding its treatment in Korean medicine.Conclusion: Further clinical research on malignant lymphoma is needed to develop a more advanced clinical guideline.
정현식(Jung Hyun Sik),박형식(Park Hyeoung Sik),박태섭(Park Tae Sub),박진형(Park Jin hyeoung),김영록(Kim Young rok) 한국전문물리치료학회 2002 한국전문물리치료학회지 Vol.9 No.1
The purposes of this study were to investigate the patient satisfaction with physical therapy services and find the related factors to patient satisfaction. In this study, three hospitals were selected at large, middle, small city. Ninety subjects (53 males, 37 females) who had received physical therapy service were participated in this survey. Survey data were collected by a written questionnaire. The patient satisfaction scale had a good reliability (Cronbachs alpha=.9134). The collected data were analyzed by t-test, ANOVA, and Kruskal-Wallis. The scores of patient satisfaction with physical therapy services at large, middle, and small city were 79.67, 76.23, and 86.33 respectively. The score of patient satisfaction at small city was significantly higher than middle and large city(p<.01). There was no significant difference in patient satisfaction with physical therapy services according to gender, age, education years, occupation, marital status, religion and average monthly income. Further studies are needed to identify which specific factors are related to patient satisfaction with physical services. This information will be useful in improving the patient satisfaction.
이기종 Protocol의 Data교환을 위한 Gateway System 구현
정현식 ( Hyun-sik Jung ),강대욱 ( Dae-wook Kang ) 한국정보처리학회 2007 한국정보처리학회 학술대회논문집 Vol.14 No.2
상위(HOST)시스템은 TCP/IP 환경이 적용 되어야 하며, 하위(P/C)시스템은 BSC프로토콜을 그대로 사용가능 해야 한다. G/W시스템은 이 두가지 NETWORK환경을 모두 지원 해야 한다. LAN카드는 TCP/IP프로토콜을 지원할 것이며 BSC카드는 모뎀을 통해서 BSC 프로토콜을 지원할 것이다. 시스템은 산업용 PC보다 성능이 뛰어난 Unix시스템을 사용할것이다. G/W시스템의 역할은 각기 형태가 다른 전문을 재편성 하는 기능을 추가한다. 상위(HOST)시스템으로 부터 받는 지시 데이터의 SIZE를 하위(P/C)시스템에서 적용 가능한 수준으로 재조정 되어야 한다. 반대로 하위(P/C)시스템에서 송신되는 전문 형태를 상위(HOST)시스템에 맞게 재조정 되어야 한다.
박현덕(Hyun Duk Park),정현식(Hyun Sik Jeong),박정식(Jeung Sik Park),임성호(Sung Ho Lim),이은정(Eun Jung Lee),윤중원(Jung Won Yun),정수석(Su Suk Jung),신호철(Ho Cheol Shin),이승세(Seung Sei Lee) 대한내과학회 2002 대한내과학회지 Vol.62 No.4
Background : Cytokeratins are epithelial markers whose expressions are not lost during malignant transformation. The utility of cytokeratin fragment (Cyfra) 21-1, a new tumor marker, was investigated in 110 patients with lung cancer. The aims of this study were to confirm sensitivity of Cyfra 21-1 in detecting non-small cell cancer, to assess the potential relationship between Cyfra 21-1 and disease stage of the lung cancer. Methods : We measured serum levels of four tumor marker (NSE, CEA, SCC Ag, Cyfra 21-1) in 110 patients with lung cancer. The measurement of serum level of Cyfra 21-1 was performed with a cut off value of 3.3 ng/mL. An immunoradiometric assay was used to detect a fragment of the cytokeratin 19. The patients were grouped according to the stage of the disease and tumor type. Results : Overall sensitivity of Cyfra 21-1 was relatively high (51.8%) than others tumor markers. Sensitivity of this marker was especially high for adenocarcinoma (63.2%) and squamous cell carcinoma (54.1%). In contrast, sensitiviy of Cyfra 21-1 was relatively low for small cell lung carcinoma (40.0%). Serum levels of Cyfra 21-1 were higher in advanced nonsmall cell lung cancer than early stage disease. Conclusion : We conclude that Cyfra 21-1 is a sensitive tumor marker of nonsmall cell lung cancer, especially adenocarcinoma and also may be a useful adjunctive marker for disease monitoring.(Korean J Med 62:415-421, 2002)
진행성 병기의 소세포폐암에 대한 Etoposide , Cisplatin 복합화학요법치료의 효과
서정열(Jung Yul Suh),정현식(Hyun Sik Jeong),이승세(Seung Sei Lee) 대한내과학회 2001 대한내과학회지 Vol.61 No.6
Background : Small cell lung cancer (SCLC) disseminates early and has poor prognosis. However, SCLC is highly chemosensitive, thus chemotherapy has been established as the primary mode of treatment. This study evaluated the efficacy and toxicity of etoposide in combination with cisplatin in the treatment of extensive stage small cell lung cancer. Methods : Thirty four patients (28 males, 6 females) with previously untreated extensive stage small cell lung cancer were treated with etoposide at a dose of 100 mg/m2, IV on days 1-3 with cisplatin at 100 mg/m2, IV on day 1. The median age was 63 (range 41∼80). This combination chemotherapy was administered every 3-4 weeks. Response rate, response duration, survival, and toxicity were evaluated.Results : The response rate was 50%. The median survival time was 29 weeks. The median response duration was 17.2 weeks in responders. The toxicity was acceptable. Conclusion : This study illustrated that the combination of etoposide and cisplatin is effective in the treatment of extensive stage small cell lung cancer, and can be administered with acceptable toxicity. Although this study was not designed to be a formal comparative trial, the efficacy and toxicity observed with this regimen were found to be comparable to previous reports.(Korean J Med 61:590-596, 2001)